A61K 38/04 Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Introduced: January 1995
Last revised: January 2006
Full Title
Medicinal preparations containing peptides > Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Classification Context
- Section:
- HUMAN NECESSITIES
- Class:
- MEDICAL OR VETERINARY SCIENCE; HYGIENE
- Subclass:
- PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
Filing statistics
IPC A61K 38/04 belongs to the parent subclass A61K, which recorded 1,792,627 patent applications worldwide between 2013 and 2023. Annual filings declined from 147,606 in 2013 to 132,650 in 2023 (-10%), peaking at 177,518 applications in 2016. The most active applicants in class A61 are PHILIPS ELECTRONICS (18,523 applications), NOVARTIS (14,253 applications) and COVIDIEN (13,953 applications).
Source: EPO PATSTAT, worldwide filings
8 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 38/05 Dipeptides
- A61K 38/06 Tripeptides
- A61K 38/07 Tetrapeptides
- A61K 38/08 Peptides having 5 to 11 amino acids
- A61K 38/1 Peptides having 12 to 20 amino acids
- A61K 38/12 Cyclic peptides
- A61K 38/14 Peptides containing saccharide radicals; Derivatives thereof
- A61K 38/15 Depsipeptides; Derivatives thereof
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594